Greenwood Capital Associates’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $602K | Sell |
7,613
-296
| -4% | -$25.2K | 0.06% | 198 |
|
|
2026
Q1 | $681K | Sell |
7,909
-378
| -5% | -$33.9K | 0.08% | 169 |
|
|
2025
Q4 | $724K | Sell |
8,287
-4,922
| -37% | -$374K | 0.08% | 158 |
|
|
2025
Q3 | $756K | Buy |
13,209
+2,847
| +27% | +$164K | 0.09% | 159 |
|
|
2025
Q2 | $612K | Sell |
10,362
-74
| -0.7% | -$4.78K | 0.08% | 166 |
|
|
2025
Q1 | $764K | Buy |
10,436
+983
| +10% | +$81.2K | 0.1% | 145 |
|
|
2024
Q4 | $782K | Sell |
9,453
-2,494
| -21% | -$197K | 0.1% | 154 |
|
|
2024
Q3 | $855K | Sell |
11,947
-286
| -2% | -$20.2K | 0.11% | 146 |
|
|
2024
Q2 | $838K | Buy |
12,233
+168
| +1% | +$10K | 0.11% | 155 |
|
|
2024
Q1 | $647K | Buy |
12,065
+3,823
| +46% | +$206K | 0.09% | 172 |
|
|
2023
Q4 | $439K | Sell |
8,242
-155
| -2% | -$7.55K | 0.06% | 201 |
|
|
2023
Q3 | $417K | Sell |
8,397
-67
| -0.8% | -$3.75K | 0.06% | 202 |
|
|
2023
Q2 | $504K | Sell |
8,464
-197
| -2% | -$11.2K | 0.07% | 188 |
|
|
2023
Q1 | $491K | Sell |
8,661
-525
| -6% | -$33.7K | 0.07% | 186 |
|
|
2022
Q4 | $682K | Sell |
9,186
-903
| -9% | -$61.5K | 0.11% | 148 |
|
|
2022
Q3 | $601K | Sell |
10,089
-224
| -2% | -$13.5K | 0.1% | 161 |
|
|
2022
Q2 | $579K | Buy |
10,313
+624
| +6% | +$41K | 0.09% | 160 |
|
|
2022
Q1 | $715K | Buy |
9,689
+243
| +3% | +$16.9K | 0.19% | 103 |
|
|
2021
Q4 | $682K | Buy |
9,446
+270
| +3% | +$19.6K | 0.1% | 166 |
|
|
2021
Q3 | $703K | Sell |
9,176
-61
| -0.7% | -$4.9K | 0.11% | 151 |
|
|
2021
Q2 | $716K | Sell |
9,237
-22
| -0.2% | -$1.56K | 0.11% | 150 |
|
|
2021
Q1 | $571K | Sell |
9,259
-179
| -2% | -$11.3K | 0.09% | 167 |
|
|
2020
Q4 | $616K | Buy |
9,438
+1,758
| +23% | +$101K | 0.1% | 143 |
|
|
2020
Q3 | $380K | Buy |
7,680
+2,463
| +47% | +$127K | 0.07% | 146 |
|
|
2020
Q2 | $249K | Buy |
5,217
+302
| +6% | +$14.6K | 0.06% | 161 |
|
|
2020
Q1 | $209K | Sell |
4,915
-404
| -8% | -$20K | 0.06% | 141 |
|
|
2019
Q4 | $313K | Buy |
5,319
+1,316
| +33% | +$71.4K | 0.07% | 154 |
|
|
2019
Q3 | $205K | Buy |
+4,003
| New | +$191K | 0.05% | 163 |
|
|
2018
Q4 | – | Sell |
-3,656
| Closed | -$208K | – | 182 |
|
|
2018
Q3 | $208K | Buy |
+3,656
| New | +$192K | 0.05% | 182 |
|
|
2018
Q2 | – | Sell |
-4,701
| Closed | -$234K | – | 207 |
|
|
2018
Q1 | $234K | Sell |
4,701
-251
| -5% | -$11.8K | 0.06% | 169 |
|
|
2017
Q4 | $204K | Buy |
+4,952
| New | +$173K | 0.05% | 206 |
|
Other funds holding GMED
JT
SC
Greenwood Capital Associates's GMED Position: Q2 2026 in Review
Greenwood Capital Associates reduced its Globus Medical (GMED) stake by 3.7% in Q2 2026, selling an estimated $25.2K and leaving 7,613 shares worth $602K. The position accounts for 0.06% of the portfolio, ranked #198.
Greenwood Capital Associates first reported a position in GMED in Q4 2017 and has held it in 31 quarters since. The position peaked at $855K in Q3 2024. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Greenwood Capital Associates held 7,613 shares of Globus Medical worth $602K as of Q2 2026.
- Greenwood Capital Associates sold 296 Globus Medical shares in Q2 2026, an estimated $25.2K.
- Globus Medical made up 0.06% of Greenwood Capital Associates's portfolio in Q2 2026, its #198 holding.
- Greenwood Capital Associates first reported a position in Globus Medical in Q4 2017 and has held it in 31 quarters since.
- Greenwood Capital Associates's Globus Medical position peaked at $855K in Q3 2024.
- 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.